COVID-19 Vaccines Market Opportunity Assessment, Epidemiology, Disease Management, Clinical Trials, Unmet Needs and Forecast to 2026

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

COVID-19 Vaccines Market Report Overview

The sales of COVID-19 vaccines across the 7MM reached $25 billion in 2021 and consisted of Tour authorized products: Comirnaty, Spikevax, Vaxzevria, and Jcovden. the COVID-19 vaccines market declined across the 7MM in 2022 as most individuals completed primary vaccinations and received at least one dose of an updated bivalent mRNA booster vaccine. Overall, the COVID-19 vaccines market is expected to significantly decline across the 7MM during the forecast period, at a negative compound annual growth rate (CAGR) of 14.5% during 2021 – 2026.

COVID-19 Vaccines Market Outlook, 2021-2026 ($ Billion)

COVID-19 Vaccines Market Outlook, 2021-2026 ($ Billion)

Buy the Report to Get Full Access to the COVID-19 Vaccines Market Forecast or Download a Free Report Sample

The COVID-19 Vaccines market research report provides a forecast model for the COVID-19 Vaccines market through 2026 as well as an overview of the disease, including epidemiology, symptoms, diagnosis, and disease management.

Market Size (2022) $25 billion
CAGR (2022 – 2032) <(14)%
Forecast Period 2021-2026
Key Countries ·       The US

·       France

·       Germany

·       Italy

·       Spain

·       The UK

·       Japan

Leading Players ·       Comirnaty (tozinameran/BNT162b2)

·       Jcovden (Ad26.COV2.S)

·       Vaxzevria (AZD-1222)

·       Nuvaxovid (NVX-CoV2373)

·       VLA-2001

·       VidPrevtyn Beta (SP-0253)

Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

COVID-19 Vaccines Market Dynamics

The sales of COVID-19 vaccines is forecast to peak in 2023 due to the launch of further updated vaccines by Moderna, Pfizer/BioNTech, and Novavax, which target the currently dominant Omicron XBB.1.5 variant. On the other hand, in 2026, sales of COVID-19 vaccines across the 7MM are forecast to decrease as the pandemic winds down and the need for annual vaccinations and/or boosters becomes less urgent.

Buy the Report to Get Full Access to the COVID-19 Vaccines Market Dynamics or Download a Free Sample Report

COVID-19 Vaccines Market Segmentation by Countries

Some of the key countries in the COVID-19 vaccines market are the US, France, Germany, Italy, Spain, the UK, and Japan. The US represented the largest COVID-19 vaccine market in 2021, followed by Japan. These countries are expected to continue leading the market in 2026.

In 2023, primary course vaccination coverage is expected to be the highest in Italy, while it is forecast to be the lowest in the UK.

COVID-19 Vaccines Market Analysis by Countries, 2023 (%)

COVID-19 Vaccines Market Analysis by Countries, 2023 (%)

Buy the Report to Get Full Access to the country insights of the COVID-19 Vaccines market, Download a Free Sample Report

COVID-19 Vaccines Market - Competitive Landscape

Some of the key players in the COVID-19 vaccines market are Comirnaty (tozinameran/BNT162b2), Jcovden (Ad26.COV2.S), Vaxzevria (AZD-1222), Nuvaxovid (NVX-CoV2373), VLA-2001, VidPrevtyn Beta (SP-0253) among others. Comirnaty (tozinameran/BNT162b2) is the first COVID-19 vaccine and mRNA-based vaccine to gain authorization for use worldwide, leading to a significant first-mover advantage.

Segments Covered in the Report

COVID-19 Vaccines Country Outlook (Value, $ Billion, 2021-2026)

  • The US
  • France
  • Germany
  • Italy
  • Spain
  • The UK
  • Japan


This report provides:

  • Overview of Coronavirus disease 2019 (COVID-19) including classification of SARS-CoV-2, etiology, pathophysiology, and epidemiology of COVID-19
  • Timeline of COVID-19 outbreak and vaccine development.
  • Current treatment options including product profiles for COVID-19 vaccines authorized in the 7MM.
  • Analysis of unmet needs and R&A strategies within the COVID-19 market.
  • Pipeline analysis including product profiles for leading vaccine candidates in the 7MM.
  • COVID-19 vaccines market outlook including revenue breakdown by market, vaccine type, and leading vaccine products from 2021-2026.

Key Highlights

• Report deliverables include a Pdf and an Excel-based forecast model

• Forecast includes the 7 major markets (7MM)

• Forecast covers the period 2021-2026

Reasons to Buy

The report will enable you to:

  • Understand the trends shaping and driving the COVID-19 vaccines market.
  • Identify the innovative technologies and key players leading the COVID-19 vaccines field.
  • Recognize gaps and areas of unmet need within the COVID-19 vaccines market.
  • Determine the current and future outlook for COVID-19 vaccines according to key opinion leaders (KOLs).
  • Track COVID-19 vaccine sales from 2021-2026.

Novavax Inc
Pfizer Inc
BioNTech SE
Vaxxinity Inc
Arcturus Therapeutics
Bavarian Nordic AS
Johnson & Johnson
GlaxoSmithKline AG
Laboratorios Hipra SA
Valneva SE
SK Bioscience Ltd
Daiichi Sankyo Co Ltd
Takeda AS
Shionogi & Co Ltd
Inovio Pharmaceuticals Inc

Table of Contents

1 Preface

1.1 Contents

1.2 Abbreviations

1.3 Related Reports

2 Executive Summary

3 Disease Overview

3.1 Timeline of COVID-19 Outbreak and Vaccine Development

3.2 COVID-19 Vaccines SWOT Analysis

3.1 Classification of SARS-CoV-2

3.2 Etiology and Pathophysiology of COVID-19

4 Epidemiology

5 Current Treatment Options

5.1 The Early SARS-CoV-2 Vaccination Landscape: 2020-2021

5.2 The Current SARS-CoV-2 Vaccination Landscape

5.3 Marketed/Authorized COVID-19 Vaccines in the 7MM

5.4 Product Profiles

5.5 COVID-19 Therapeutic Landscape

6 Unmet Needs and Opportunities

6.1 Unmet Needs in COVID-19 Vaccination

7 R&D Strategies

7.1 Trends in Clinical Trial Design

7.2 Trends in Deal-Making for COVID-19 Vaccines (2020-Present)

8 Pipeline Assessment

8.1 COVID-19 Vaccines Pipeline Overview

8.2 COVID-19 Vaccines: Clinical Trials (Phase II/III) Overview

8.3 Leading Pipeline Vaccine Candidates in the 7MM

9 Market Outlook

9.1 COVID-19 Vaccines: Market Forecast

9.2 COVID-19 Vaccines: Market Drivers and Barriers

10 Appendix

10.1 Primary Research: KOL Information

10.2 Bibliography

10.3 About the Authors

11 Contact Us

Frequently asked questions

COVID-19 Vaccines Market Opportunity Assessment, Epidemiology, Disease Management, Clinical Trials, Unmet Needs and Forecast to 2026 thematic reports
Currency USD

Can be used by individual purchaser only


Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

COVID-19 Vaccines Market Opportunity Assessment, Epidemiology, Disease Management, Clinical Trials, Unmet Needs and Forecast to 2026 was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at COVID-19 Vaccines Market Opportunity Assessment, Epidemiology, Disease Management, Clinical Trials, Unmet Needs and Forecast to 2026 in real time.

  • Access a live COVID-19 Vaccines Market Opportunity Assessment, Epidemiology, Disease Management, Clinical Trials, Unmet Needs and Forecast to 2026 dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.